Cite
HARVARD Citation
Lukina, E. et al. (n.d.). Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial. American journal of hematology. 94 (1), pp. 29-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lukina, E. et al. (n.d.). Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial. American journal of hematology. 94 (1), pp. 29-38. [Online].